Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0AD4Z
|
|||
| Drug Name |
Fasinumab
|
|||
| Indication | Chronic low back pain [ICD-11: MG30.02] | Phase 3 | [1] | |
| Neuropathic pain [ICD-11: 8E43.0] | Phase 3 | [1] | ||
| Osteoarthritis [ICD-11: FA00-FA05] | Phase 3 | [1] | ||
| Pain [ICD-11: MG30-MG3Z] | Phase 3 | [1] | ||
| Company |
Regeneron Pharmaceuticals Tarrytown, NY Teva Pharmaceuticals USA North Wales, PA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.